Correlation Between Terns Pharmaceuticals and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Cullinan Oncology LLC, you can compare the effects of market volatilities on Terns Pharmaceuticals and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Cullinan Oncology.
Diversification Opportunities for Terns Pharmaceuticals and Cullinan Oncology
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Terns and Cullinan is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Cullinan Oncology
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 1.94 times more return on investment than Cullinan Oncology. However, Terns Pharmaceuticals is 1.94 times more volatile than Cullinan Oncology LLC. It trades about -0.13 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.65 per unit of risk. If you would invest 418.00 in Terns Pharmaceuticals on November 30, 2024 and sell it today you would lose (49.00) from holding Terns Pharmaceuticals or give up 11.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. Cullinan Oncology LLC
Performance |
| Timeline |
| Terns Pharmaceuticals |
| Cullinan Oncology LLC |
Terns Pharmaceuticals and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and Cullinan Oncology
The main advantage of trading using opposite Terns Pharmaceuticals and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | ||
| Terns Pharmaceuticals vs. Acumen Pharmaceuticals | ||
| Terns Pharmaceuticals vs. Inozyme Pharma | ||
| Terns Pharmaceuticals vs. X4 Pharmaceuticals |
| Cullinan Oncology vs. Bolt Biotherapeutics | ||
| Cullinan Oncology vs. Day One Biopharmaceuticals | ||
| Cullinan Oncology vs. Lyra Therapeutics | ||
| Cullinan Oncology vs. Autolus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |